Research and Markets: Chinese Markets for Health Care - Forecasts up to 2021 Features Companies Nanjing Medical Co., Ltd. and Jiangxi Huiren Group Co., Ltd.

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xwfnd5/chinese_markets) has announced the addition of the "Chinese Markets for Health Care" report to their offering.

China's demand for health care has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.

Companies Mentioned:

Lizhu Pharmaceutical Group Stockholder- owned Co., Ltd.

Tianjin Pharmaceutical Group Co., Ltd.

Shandong Lukang Pharmaceutical Group Co., Ltd.

Taiji Pharmaceutical Group Co., Ltd.

Hearts K Group Stockholder-owned Co., Ltd.

Sino-America Tianjian Shike Pharmaceutical Co., Ltd.

Hebei Gaoying Enterprise Group Corporation

Sino-America Shanghai Shibaogui Pharmaceutical Co., Ltd.

Key Topics Covered:

I. INTRODUCTION

II. BUSINESS ENVIRONMENT

III. HEALTH CARE INDUSTRY ASSESSMENTS

IV. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS

V. HEALTH CARE MARKET OUTLOOKS

VI. MARKETING STRATEGIES

VII. HEALTH CARE PRODUCER DIRECTORY

LIST OF TABLES

LIST OF CHARTS

For more information visit http://www.researchandmarkets.com/research/xwfnd5/chinese_markets